Dynavax (NASDAQ: DVAX) reported Q4 EPS of $0.45, $0.04 better than the analyst estimate of $0.41. Revenue for the quarter came in at $184.5 million versus the consensus estimate of $179.6 million.

For earnings history and earnings-related data on Dynavax (DVAX) click here.